Plasma antithrombin III and protein C levels in early recognition of late-onset sepsis in newborns. 2006

Ryszard Lauterbach, and Dorota Pawlik, and Renata Radziszewska, and Joanna Woźniak, and Krzysztof Rytlewski
Department of Neonatology, Jagiellonian University Medical College, Kopernika 23, 31-501 Cracow, Poland. ryszard@lauterbach.pl

OBJECTIVE The aim of this prospective, observational study was to establish the prognostic values of plasma antithrombin III (ATIII) and protein C (PC) functional levels, determined in 150 neonates with suspected late-onset sepsis. METHODS Both the ATIII and PC concentrations were significantly lower in neonates with sepsis, either confirmed or not confirmed by blood culture, than data obtained in infants with excluded disease. The lowest values of plasma ATIII and PC were observed in neonates who had died in the course of sepsis. The differences between survivors and non-survivors were statistically significant (respectively, for ATIII P=0.003 and for PC P=0.00002). A highly statistically significant correlation (P=0.0016) between plasma PC functional level and risk of death was found in patients with sepsis. However, plasma ATIII concentration, evaluated in the same group of patients, did not correlate with the occurrence of death. CONCLUSIONS We concluded that the measurement of plasma ATIII and, especially, PC levels may facilitate the recognition of sepsis and, with respect to PC, may have a prognostic value. Plasma PC functional concentration below 10% might be the indication for supplementation of PC concentrate.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D011044 Poland A country in central Europe, east of Germany. The capital is Warsaw. Polish People's Republic,Republic of Poland
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011486 Protein C A vitamin-K dependent zymogen present in the blood, which, upon activation by thrombin and thrombomodulin exerts anticoagulant properties by inactivating factors Va and VIIIa at the rate-limiting steps of thrombin formation.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses
D000990 Antithrombin III A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily. Heparin Cofactor I,Antithrombin III-Alpha,Atenativ,Heparin Co-Factor I,Kybernin,Serpin C1,Thrombate III,Antithrombin III Alpha,Antithrombin IIIAlpha,Cofactor I, Heparin,Heparin Co Factor I
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

Ryszard Lauterbach, and Dorota Pawlik, and Renata Radziszewska, and Joanna Woźniak, and Krzysztof Rytlewski
January 1989, Pediatric hematology and oncology,
Ryszard Lauterbach, and Dorota Pawlik, and Renata Radziszewska, and Joanna Woźniak, and Krzysztof Rytlewski
January 2010, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies,
Ryszard Lauterbach, and Dorota Pawlik, and Renata Radziszewska, and Joanna Woźniak, and Krzysztof Rytlewski
March 2004, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies,
Ryszard Lauterbach, and Dorota Pawlik, and Renata Radziszewska, and Joanna Woźniak, and Krzysztof Rytlewski
January 1998, The Journal of international medical research,
Ryszard Lauterbach, and Dorota Pawlik, and Renata Radziszewska, and Joanna Woźniak, and Krzysztof Rytlewski
January 2023, Pediatrics in review,
Ryszard Lauterbach, and Dorota Pawlik, and Renata Radziszewska, and Joanna Woźniak, and Krzysztof Rytlewski
January 1997, Acta neurochirurgica,
Ryszard Lauterbach, and Dorota Pawlik, and Renata Radziszewska, and Joanna Woźniak, and Krzysztof Rytlewski
January 1990, Acta paediatrica Scandinavica,
Ryszard Lauterbach, and Dorota Pawlik, and Renata Radziszewska, and Joanna Woźniak, and Krzysztof Rytlewski
February 2005, Transfusion,
Ryszard Lauterbach, and Dorota Pawlik, and Renata Radziszewska, and Joanna Woźniak, and Krzysztof Rytlewski
June 2021, Fetal and pediatric pathology,
Ryszard Lauterbach, and Dorota Pawlik, and Renata Radziszewska, and Joanna Woźniak, and Krzysztof Rytlewski
October 1984, Thrombosis and haemostasis,
Copied contents to your clipboard!